At Reactosome are building a synthetic nucleus — to enable the safest gene therapies with largest cargo.
Our synthetic nuclei once inside cells operate continuously, mirroring cell own nucleus in function. And this method allows us to achieve way longer expression than any RNA-based solutions, without any safety concerns of the DNA-based ones.
Company Details
- Employees
- 6
- Founded
- -
- Address
- San Francisco, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://reactosome.com/
- Keywords
- biotech, synbio, RNA therapeutics.
- HQ
- San Francisco
Reactosome Questions
Reactosome's website is https://reactosome.com/
Reactosome's LinkedIn profile is https://www.linkedin.com/company/reactosome
Reactosome has
6 employees.
View email and phone details for 6
employees at Reactosome.
Reactosome's industry is
Biotechnology Research
Reactosome's top competitors are
Olfera,
Silica Corpora,
Voro Therapeutics,
Biolabs Heidelberg,
Tippingpoint Biosciences,
Mimbiosis,
Nucleate Germany,
Revobits,
Sift Biosciences,
Jellyfish Bio.
Reactosome's categories are Biotechnology Research
Reactosome's founding year is 2023
